Healthcare Sector Stocks
The Healthcare sector has a total of 1045 stocks, with a combined market cap of $9.22 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 48.70.
Market Cap
9.22T
Revenue
4.67T
Profits
189.21B
PE Ratio
48.70
Profit Margin
4.06%
Dividend Yield
0.38%
1046 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.02T | 0.56% | 577,375 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 645.68B | 0.24% | 2,030,212 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 464.35B | 0.10% | 774,416 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 362.46B | 1.38% | 2,264,889 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 339.31B | 0.74% | 1,411,273 | 450.53B |
| 6 | NVS | Novartis AG | 265.19B | 1.29% | 690,643 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 253.14B | 1.80% | 1,850,102 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 242.07B | 0.97% | 1,342,009 | 46.34B |
| 9 | AMGN | Amgen Inc. | 206.20B | 1.34% | 1,093,917 | 38.10B |
| 10 | NVO | Novo Nordisk A/S | 186.08B | 3.09% | 6,292,542 | 50.34B |
| 11 | GILD | Gilead Sciences, Inc. | 185.36B | 1.23% | 1,969,358 | 30.46B |
| 12 | ABT | Abbott Laboratories | 175.15B | -1.11% | 2,617,304 | 46.59B |
| 13 | PFE | Pfizer Inc. | 157.82B | 0.84% | 9,260,228 | 63.70B |
| 14 | DHR | Danaher Corporation | 148.61B | 1.46% | 1,626,284 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 135.06B | - | 696,386 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 130.33B | 0.18% | 254,930 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 129.45B | -0.36% | 3,988,909 | 49.19B |
| 18 | MDT | Medtronic plc | 118.61B | 0.14% | 2,010,330 | 37.54B |
| 19 | CVS | CVS Health Corporation | 116.90B | -0.35% | 2,199,497 | 412.65B |
| 20 | SYK | Stryker Corporation | 107.52B | -1.56% | 570,483 | 25.84B |
| 21 | SNY | Sanofi | 102.79B | 1.13% | 2,030,716 | 55.89B |
| 22 | MCK | McKesson Corporation | 102.37B | -1.04% | 185,360 | 410.98B |
| 23 | GSK | GSK plc | 101.65B | 0.97% | 1,450,228 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 93.71B | 0.56% | 385,187 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 90.10B | 0.70% | 517,933 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 78.04B | 0.89% | 171,125 | 15.53B |
| 27 | CI | The Cigna Group | 73.56B | -0.73% | 315,881 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 62.69B | -1.48% | 9,636,342 | 21.00B |
| 29 | MRNA | Moderna, Inc. | 62.13B | 6.87% | 11,942,995 | 2.23B |
| 30 | ARGX | argenx SE | 61.24B | 0.91% | 112,636 | 5.32B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 61.22B | 2.23% | 1,344,585 | 28.42B |
| 32 | COR | Cencora, Inc. | 59.67B | -1.82% | 263,108 | 332.77B |
| 33 | CAH | Cardinal Health, Inc. | 52.93B | -2.12% | 464,419 | 254.25B |
| 34 | NTRA | Natera, Inc. | 51.99B | 4.44% | 568,737 | 2.71B |
| 35 | EW | Edwards Lifesciences Corporation | 50.92B | -1.05% | 1,235,905 | 6.51B |
| 36 | BDX | Becton, Dickinson and Company | 50.15B | 1.25% | 508,259 | 22.48B |
| 37 | HUM | Humana Inc. | 46.48B | 0.60% | 277,087 | 145.68B |
| 38 | TEVA | Teva Pharmaceutical Industries Limited | 45.87B | 2.15% | 2,231,539 | 17.32B |
| 39 | IQV | IQVIA Holdings Inc. | 44.80B | 1.24% | 644,212 | 16.98B |
| 40 | A | Agilent Technologies, Inc. | 43.84B | 1.18% | 531,044 | 7.37B |
| 41 | VEEV | Veeva Systems Inc. | 42.96B | 0.15% | 418,104 | 3.46B |
| 42 | MDLN | Medline Inc. | 42.71B | -1.52% | 2,236,869 | 29.94B |
| 43 | RVMD | Revolution Medicines, Inc. | 42.26B | 0.63% | 859,207 | - |
| 44 | WAT | Waters Corporation | 41.97B | 2.03% | 224,744 | 4.64B |
| 45 | HLN | Haleon plc | 40.25B | -0.05% | 13,728,805 | 14.80B |
| 46 | IDXX | IDEXX Laboratories, Inc. | 40.10B | -0.90% | 122,532 | 4.55B |
| 47 | ONC | BeOne Medicines AG | 40.09B | 1.30% | 146,740 | 6.13B |
| 48 | ILMN | Illumina, Inc. | 36.79B | 6.43% | 1,434,512 | 4.49B |
| 49 | RPRX | Royalty Pharma plc | 33.75B | 0.39% | 689,726 | 2.54B |
| 50 | CNC | Centene Corporation | 33.16B | 1.70% | 1,491,221 | 180.30B |
| 51 | DXCM | DexCom, Inc. | 33.11B | 0.46% | 806,200 | 4.97B |
| 52 | ALC | Alcon Inc. | 32.52B | -2.32% | 627,139 | 10.86B |
| 53 | RMD | ResMed Inc. | 32.42B | -0.72% | 358,915 | 5.65B |
| 54 | BIIB | Biogen Inc. | 32.21B | 0.94% | 254,731 | 10.03B |
| 55 | ALNY | Alnylam Pharmaceuticals, Inc. | 32.10B | 0.24% | 334,159 | 4.80B |
| 56 | ZTS | Zoetis Inc. | 29.88B | -0.96% | 1,808,094 | 9.53B |
| 57 | GEHC | GE HealthCare Technologies Inc. | 28.97B | 1.01% | 1,244,204 | 21.27B |
| 58 | ROIV | Roivant Sciences Ltd. | 28.65B | 0.23% | 2,822,677 | 7.53M |
| 59 | MTD | Mettler-Toledo International Inc. | 28.34B | 2.58% | 103,427 | 4.13B |
| 60 | DGX | Quest Diagnostics Incorporated | 27.37B | 0.38% | 307,874 | 11.56B |
| 61 | INSM | Insmed Incorporated | 27.02B | 0.93% | 650,782 | 1.14B |
| 62 | LH | Labcorp Holdings Inc. | 26.30B | -0.06% | 183,773 | 14.35B |
| 63 | WST | West Pharmaceutical Services, Inc. | 25.88B | 1.58% | 163,942 | 3.33B |
| 64 | INCY | Incyte Corporation | 25.63B | 1.37% | 300,447 | 5.82B |
| 65 | BNTX | BioNTech SE | 24.72B | 2.67% | 289,080 | 3.03B |
| 66 | PHG | Koninklijke Philips N.V. | 24.46B | -0.28% | 366,640 | 20.18B |
| 67 | GH | Guardant Health, Inc. | 24.16B | 2.95% | 684,260 | 1.18B |
| 68 | UTHR | United Therapeutics Corporation | 21.20B | -0.83% | 138,102 | 3.15B |
| 69 | THC | Tenet Healthcare Corporation | 21.18B | -1.02% | 238,760 | 21.81B |
| 70 | GMAB | Genmab A/S | 20.39B | 0.45% | 1,634,651 | 4.13B |
| 71 | STE | STERIS plc | 20.29B | -0.88% | 246,105 | 6.04B |
| 72 | VTRS | Viatris Inc. | 19.80B | 1.29% | 2,426,444 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 18.11B | -1.87% | 600,300 | 8.51B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.33B | 0.73% | 74,523 | 2.78B |
| 75 | RVTY | Revvity, Inc. | 16.65B | 2.38% | 1,083,395 | 2.91B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 15.92B | 0.69% | 175,290 | 4.60B |
| 77 | ASND | Ascendis Pharma A/S | 15.72B | -3.37% | 391,131 | 1.20B |
| 78 | NBIX | Neurocrine Biosciences, Inc. | 15.45B | 1.67% | 204,893 | 3.37B |
| 79 | SOLV | Solventum Corporation | 14.97B | -0.97% | 211,889 | 8.31B |
| 80 | TEM | Tempus AI, Inc. | 14.42B | 14.21% | 11,363,191 | 1.43B |
| 81 | EXEL | Exelixis, Inc. | 14.39B | 2.31% | 509,926 | 2.44B |
| 82 | SMMT | Summit Therapeutics Inc. | 14.23B | 3.12% | 2,603,416 | - |
| 83 | CRL | Charles River Laboratories International, Inc. | 13.56B | 3.88% | 299,728 | 4.00B |
| 84 | ICLR | ICON Public Limited Company | 13.33B | -0.66% | 598,950 | 8.29B |
| 85 | BBIO | BridgeBio Pharma, Inc. | 13.21B | -1.05% | 704,390 | 713.07M |
| 86 | BMRN | BioMarin Pharmaceutical Inc. | 12.74B | 1.71% | 408,639 | 3.41B |
| 87 | PEN | Penumbra, Inc. | 12.54B | -0.02% | 72,878 | 1.50B |
| 88 | HALO | Halozyme Therapeutics, Inc. | 12.49B | 1.47% | 869,574 | 1.66B |
| 89 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.25B | 0.24% | 68,673 | 1.28B |
| 90 | FMS | Fresenius Medical Care AG | 12.24B | -2.76% | 381,837 | 22.19B |
| 91 | EHC | Encompass Health Corporation | 12.20B | -0.20% | 169,169 | 6.21B |
| 92 | BTSG | BrightSpring Health Services, Inc. | 12.18B | -0.81% | 702,380 | 14.37B |
| 93 | CORT | Corcept Therapeutics Incorporated | 12.11B | 0.23% | 225,802 | 830.81M |
| 94 | DVA | DaVita Inc. | 12.08B | -2.26% | 214,645 | 14.01B |
| 95 | BAX | Baxter International Inc. | 12.07B | -0.81% | 2,272,998 | 11.47B |
| 96 | SNN | Smith & Nephew plc | 11.79B | -0.25% | 571,162 | 6.30B |
| 97 | ELAN | Elanco Animal Health Incorporated | 11.56B | 1.20% | 1,702,989 | 5.02B |
| 98 | TECH | Bio-Techne Corporation | 11.36B | 0.17% | 1,704,461 | 1.22B |
| 99 | AXSM | Axsome Therapeutics, Inc. | 11.11B | 0.10% | 216,346 | 776.57M |
| 100 | MOH | Molina Healthcare, Inc. | 10.86B | 3.10% | 178,396 | 42.47B |
| 101 | AVTR | Avantor, Inc. | 10.81B | 2.37% | 3,993,073 | 6.56B |
| 102 | ALGN | Align Technology, Inc. | 10.80B | 1.00% | 222,658 | 4.14B |
| 103 | UHS | Universal Health Services, Inc. | 10.72B | 0.41% | 342,666 | 18.11B |
| 104 | BIO | Bio-Rad Laboratories, Inc. | 10.24B | 1.07% | 77,395 | 2.59B |
| 105 | TXG | 10x Genomics, Inc. | 10.24B | 8.10% | 1,528,087 | 616.91M |
| 106 | RDY | Dr. Reddy's Laboratories Limited | 10.18B | 5.05% | 1,674,877 | 3.50B |
| 107 | OSCR | Oscar Health, Inc. | 10.16B | 1.92% | 2,499,410 | 15.32B |
| 108 | COO | The Cooper Companies, Inc. | 10.09B | -2.82% | 1,779,391 | 4.24B |
| 109 | ENSG | The Ensign Group, Inc. | 10.09B | -1.83% | 103,726 | 5.49B |
| 110 | GMED | Globus Medical, Inc. | 10.07B | -0.36% | 417,065 | 3.14B |
| 111 | RGEN | Repligen Corporation | 10.00B | 2.51% | 311,029 | 785.10M |
| 112 | TWST | Twist Bioscience Corporation | 9.98B | 11.29% | 1,749,950 | 431.80M |
| 113 | KRYS | Krystal Biotech, Inc. | 9.98B | 0.10% | 47,138 | 440.48M |
| 114 | KYMR | Kymera Therapeutics, Inc. | 9.92B | 2.56% | 206,491 | 105.00M |
| 115 | BRKR | Bruker Corporation | 9.75B | 5.49% | 1,131,153 | 3.50B |
| 116 | PODD | Insulet Corporation | 9.73B | -0.21% | 275,626 | 3.05B |
| 117 | GKOS | Glaukos Corporation | 9.67B | 0.33% | 171,341 | 612.84M |
| 118 | CYTK | Cytokinetics, Incorporated | 9.64B | -0.10% | 403,576 | 67.67M |
| 119 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.57B | 2.98% | 1,537,157 | 669.50M |
| 120 | HSIC | Henry Schein, Inc. | 9.52B | -1.51% | 718,598 | 13.60B |
| 121 | ABVX | ABIVAX Société Anonyme | 9.38B | 3.17% | 615,063 | 5.67M |
| 122 | PTGX | Protagonist Therapeutics, Inc. | 9.29B | 0.56% | 143,485 | 281.99M |
| 123 | QGEN | Qiagen N.V. | 9.13B | 2.87% | 871,118 | 2.10B |
| 124 | IBRX | ImmunityBio, Inc. | 9.07B | 8.22% | 10,193,043 | 165.79M |
| 125 | PCVX | Vaxcyte, Inc. | 9.03B | 3.25% | 499,508 | - |
| 126 | CAI | Caris Life Sciences, Inc. | 8.66B | 8.58% | 3,961,733 | 989.61M |
| 127 | PRAX | Praxis Precision Medicines, Inc. | 8.58B | -0.49% | 307,832 | 7.46M |
| 128 | SYRE | Spyre Therapeutics, Inc. | 8.17B | 1.58% | 366,728 | - |
| 129 | TGTX | TG Therapeutics, Inc. | 8.01B | 1.16% | 526,203 | 799.54M |
| 130 | ATR | AptarGroup, Inc. | 7.99B | 0.76% | 102,020 | 3.93B |
| 131 | HQY | HealthEquity, Inc. | 7.87B | -0.94% | 149,477 | 1.36B |
| 132 | ALKS | Alkermes plc | 7.81B | 1.06% | 493,422 | 1.67B |
| 133 | IONS | Ionis Pharmaceuticals, Inc. | 7.74B | 3.86% | 1,394,275 | 874.09M |
| 134 | HNGE | Hinge Health, Inc. | 7.67B | 1.43% | 801,424 | 720.06M |
| 135 | IMVT | Immunovant, Inc. | 7.60B | 1.15% | 378,862 | - |
| 136 | BLTE | Belite Bio, Inc | 6.91B | 1.36% | 49,489 | - |
| 137 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.85B | 1.51% | 291,550 | 239.92M |
| 138 | PACS | PACS Group, Inc. | 6.78B | 0.26% | 143,985 | 5.55B |
| 139 | CGON | CG Oncology, Inc. | 6.65B | 1.28% | 169,978 | 6.23M |
| 140 | LNTH | Lantheus Holdings, Inc. | 6.59B | 0.39% | 101,450 | 1.56B |
| 141 | CHE | Chemed Corporation | 6.59B | -0.75% | 70,941 | 2.60B |
| 142 | GRFS | Grifols, S.A. | 6.58B | -0.07% | 88,602 | 8.48B |
| 143 | HIMS | Hims & Hers Health, Inc. | 6.48B | -0.75% | 4,426,027 | 2.58B |
| 144 | AMRX | Amneal Pharmaceuticals, Inc. | 6.39B | 1.55% | 1,067,111 | 3.12B |
| 145 | MIRM | Mirum Pharmaceuticals, Inc. | 6.34B | 0.29% | 250,553 | 618.07M |
| 146 | STVN | Stevanato Group S.p.A. | 6.28B | 2.04% | 235,159 | 1.40B |
| 147 | ORKA | Oruka Therapeutics, Inc. | 6.24B | 0.77% | 233,968 | - |
| 148 | LQDA | Liquidia Corporation | 6.23B | 1.64% | 250,943 | 450.91M |
| 149 | MMED | MiniMed Group, Inc. | 6.20B | -1.65% | 739,151 | 3.22B |
| 150 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.14B | 1.42% | 198,666 | 840.85M |
| 151 | TVTX | Travere Therapeutics, Inc. | 6.08B | 1.54% | 309,256 | 591.33M |
| 152 | BLCO | Bausch + Lomb Corporation | 6.06B | -0.64% | 55,976 | 5.32B |
| 153 | RDNT | RadNet, Inc. | 6.02B | 0.87% | 85,649 | 2.27B |
| 154 | SRRK | Scholar Rock Holding Corporation | 5.94B | -1.17% | 961,829 | - |
| 155 | COGT | Cogent Biosciences, Inc. | 5.77B | 2.12% | 411,519 | - |
| 156 | DNTH | Dianthus Therapeutics, Inc. | 5.67B | -1.12% | 427,753 | 1.90M |
| 157 | PTCT | PTC Therapeutics, Inc. | 5.66B | 0.33% | 408,840 | 1.01B |
| 158 | LGND | Ligand Pharmaceuticals Incorporated | 5.63B | 2.60% | 67,455 | 290.54M |
| 159 | XENE | Xenon Pharmaceuticals Inc. | 5.55B | 0.92% | 431,029 | 7.50M |
| 160 | CRSP | CRISPR Therapeutics AG | 5.50B | 8.93% | 1,499,615 | 13.39M |
| 161 | ERAS | Erasca, Inc. | 5.49B | 2.28% | 1,381,619 | - |
| 162 | SHC | Sotera Health Company | 5.48B | -0.67% | 458,369 | 1.22B |
| 163 | TFX | Teleflex Incorporated | 5.34B | -1.62% | 185,771 | 2.25B |
| 164 | DFTX | Definium Therapeutics, Inc. | 5.18B | 1.85% | 742,770 | - |
| 165 | BLLN | BillionToOne, Inc. | 5.14B | 5.05% | 142,154 | 397.41M |
| 166 | MMSI | Merit Medical Systems, Inc. | 5.12B | -0.44% | 71,117 | 1.58B |
| 167 | EWTX | Edgewise Therapeutics, Inc. | 5.08B | 3.04% | 830,890 | - |
| 168 | WAY | Waystar Holding Corp. | 5.07B | -0.53% | 613,100 | 1.21B |
| 169 | PBLS | Parabilis Medicines, Inc. | 5.03B | 10.47% | 504,590 | 148.00K |
| 170 | HAE | Haemonetics Corporation | 4.96B | 2.65% | 175,600 | 1.35B |
| 171 | LFST | LifeStance Health Group, Inc. | 4.93B | 0.86% | 4,510,756 | 1.58B |
| 172 | ACAD | ACADIA Pharmaceuticals Inc. | 4.73B | -0.22% | 492,819 | 1.14B |
| 173 | IOVA | Iovance Biotherapeutics, Inc. | 4.72B | 5.47% | 13,872,752 | 324.97M |
| 174 | DOCS | Doximity, Inc. | 4.61B | -0.35% | 398,230 | 655.57M |
| 175 | CON | Concentra Group Holdings Parent, Inc. | 4.58B | -1.18% | 208,900 | 2.29B |
| 176 | MANE | Veradermics, Incorporated | 4.54B | 6.07% | 314,750 | - |
| 177 | ADPT | Adaptive Biotechnologies Corporation | 4.51B | 2.10% | 1,685,599 | 308.08M |
| 178 | LIVN | LivaNova PLC | 4.33B | 0.03% | 129,754 | 1.47B |
| 179 | ITGR | Integer Holdings Corporation | 4.29B | 0.17% | 128,480 | 1.84B |
| 180 | HTFL | HeartFlow, Inc. | 4.26B | 1.37% | 436,691 | 212.07M |
| 181 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.25B | 3.89% | 453,678 | -665.00K |
| 182 | RLAY | Relay Therapeutics, Inc. | 4.25B | 2.97% | 1,225,788 | 10.35M |
| 183 | TLX | Telix Pharmaceuticals Limited | 4.23B | 5.92% | 235,047 | 890.79M |
| 184 | INDV | Indivior Pharmaceuticals, Inc. | 4.21B | 3.84% | 516,897 | 1.33B |
| 185 | CELC | Celcuity Inc. | 4.19B | 3.71% | 240,749 | - |
| 186 | ABCL | AbCellera Biologics Inc. | 4.18B | 10.54% | 4,505,982 | 66.17M |
| 187 | TNGX | Tango Therapeutics, Inc. | 4.06B | 3.13% | 615,331 | 53.81M |
| 188 | NVST | Envista Holdings Corporation | 3.89B | -3.12% | 1,886,765 | 2.86B |
| 189 | ICUI | ICU Medical, Inc. | 3.87B | -0.67% | 57,935 | 2.16B |
| 190 | IDYA | IDEAYA Biosciences, Inc. | 3.77B | 3.42% | 279,030 | 234.13M |
| 191 | ELVN | Enliven Therapeutics, Inc. | 3.73B | 3.63% | 959,898 | - |
| 192 | IRTC | iRhythm Holdings, Inc. | 3.70B | 0.35% | 176,377 | 825.34M |
| 193 | GRAL | GRAIL, Inc. | 3.60B | 7.27% | 638,853 | 165.26M |
| 194 | OPCH | Option Care Health, Inc. | 3.59B | -1.96% | 988,875 | 5.69B |
| 195 | PLSE | Pulse Biosciences, Inc. | 3.59B | 1.52% | 245,344 | 1.19M |
| 196 | OGN | Organon & Co. | 3.59B | 0.04% | 332,797 | 6.13B |
| 197 | NHC | National HealthCare Corporation | 3.53B | 0.03% | 36,790 | 1.56B |
| 198 | VKTX | Viking Therapeutics, Inc. | 3.47B | 0.68% | 804,217 | - |
| 199 | TARS | Tarsus Pharmaceuticals, Inc. | 3.42B | 0.45% | 121,463 | 606.33M |
| 200 | LEGN | Legend Biotech Corporation | 3.40B | 3.35% | 662,475 | 1.27B |
| 201 | DYN | Dyne Therapeutics, Inc. | 3.35B | 3.70% | 1,281,013 | - |
| 202 | RCUS | Arcus Biosciences, Inc. | 3.29B | 4.75% | 655,402 | 117.00M |
| 203 | DNLI | Denali Therapeutics Inc. | 3.23B | 0.85% | 405,189 | 3.60M |
| 204 | VCYT | Veracyte, Inc. | 3.18B | 2.75% | 415,743 | 561.90M |
| 205 | CLDX | Celldex Therapeutics, Inc. | 3.12B | 2.66% | 618,803 | 158.00K |
| 206 | ARQT | Arcutis Biotherapeutics, Inc. | 3.12B | -5.18% | 2,049,421 | 463.98M |
| 207 | AVAH | Aveanna Healthcare Holdings Inc. | 3.09B | -0.84% | 1,035,212 | 2.60B |
| 208 | QURE | uniQure N.V. | 3.05B | 3.39% | 281,950 | 18.67M |
| 209 | MBX | MBX Biosciences, Inc. | 3.05B | 2.72% | 392,076 | - |
| 210 | WGS | GeneDx Holdings Corp. | 3.03B | 4.19% | 266,392 | 454.43M |
| 211 | TMDX | TransMedics Group, Inc. | 3.01B | -1.01% | 191,066 | 668.47M |
| 212 | WRBY | Warby Parker Inc. | 2.97B | 2.12% | 662,210 | 911.61M |
| 213 | ATRC | AtriCure, Inc. | 2.97B | 2.17% | 526,302 | 569.62M |
| 214 | RGC | Regencell Bioscience Holdings Limited | 2.92B | 3.87% | 37,323 | - |
| 215 | GRDN | Guardian Pharmacy Services, Inc. | 2.91B | -1.35% | 202,289 | 1.46B |
| 216 | ZLAB | Zai Lab Limited | 2.89B | 4.34% | 239,575 | 449.61M |
| 217 | NEOG | Neogen Corporation | 2.83B | 3.43% | 665,095 | 870.40M |
| 218 | CDNA | CareDx, Inc. | 2.81B | 1.25% | 353,623 | 458.09M |
| 219 | PGEN | Precigen, Inc. | 2.79B | 4.77% | 3,048,460 | 85.72M |
| 220 | BKD | Brookdale Senior Living Inc. | 2.78B | -0.39% | 1,704,834 | 2.93B |
| 221 | IMNM | Immunome, Inc. | 2.74B | 2.77% | 304,688 | 4.02M |
| 222 | AXGN | Axogen, Inc. | 2.71B | 1.46% | 207,183 | 251.17M |
| 223 | PHVS | Pharvaris N.V. | 2.67B | 1.38% | 426,834 | - |
| 224 | ACHC | Acadia Healthcare Company, Inc. | 2.67B | 1.74% | 236,160 | 3.37B |
| 225 | IRON | Disc Medicine, Inc. | 2.66B | 1.15% | 280,834 | - |
| 226 | NRIX | Nurix Therapeutics, Inc. | 2.66B | 1.79% | 531,618 | 36.77M |
| 227 | NAMS | NewAmsterdam Pharma Company N.V. | 2.63B | 3.68% | 835,220 | 7.12M |
| 228 | PRVA | Privia Health Group, Inc. | 2.60B | -0.20% | 255,773 | 2.36B |
| 229 | NEO | NeoGenomics, Inc. | 2.54B | 4.33% | 647,137 | 766.30M |
| 230 | GPCR | Structure Therapeutics Inc. | 2.54B | 0.20% | 360,249 | - |
| 231 | SUPN | Supernus Pharmaceuticals, Inc. | 2.51B | 4.40% | 240,730 | 830.44M |
| 232 | MLYS | Mineralys Therapeutics, Inc. | 2.50B | 2.69% | 525,895 | - |
| 233 | CLOV | Clover Health Investments, Corp. | 2.50B | 3.07% | 1,779,304 | 2.48B |
| 234 | VRDN | Viridian Therapeutics, Inc. | 2.49B | -1.96% | 397,065 | 71.13M |
| 235 | BEAM | Beam Therapeutics Inc. | 2.47B | 7.10% | 1,286,386 | 156.04M |
| 236 | HRMY | Harmony Biosciences Holdings, Inc. | 2.47B | 0.54% | 206,931 | 959.90M |
| 237 | VERA | Vera Therapeutics, Inc. | 2.44B | 6.45% | 1,693,313 | - |
| 238 | NKTR | Nektar Therapeutics | 2.33B | 1.22% | 338,705 | 54.59M |
| 239 | SLS | SELLAS Life Sciences Group, Inc. | 2.31B | -1.72% | 2,649,694 | - |
| 240 | HCM | HUTCHMED (China) Limited | 2.27B | 2.86% | 20,821 | 549.12M |
| 241 | TRLV | Trulieve Cannabis Corp. | 2.25B | 1.04% | 523,699 | 1.14B |
| 242 | OCUL | Ocular Therapeutix, Inc. | 2.25B | 3.60% | 790,737 | 52.06M |
| 243 | AUPH | Aurinia Pharmaceuticals Inc. | 2.24B | -0.71% | 266,693 | 311.51M |
| 244 | PVLA | Palvella Therapeutics, Inc. | 2.23B | 2.07% | 69,000 | - |
| 245 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.22B | 3.08% | 1,634,010 | 940.61M |
| 246 | GENB | Generate Biomedicines, Inc. | 2.18B | 8.45% | 1,090,763 | 26.48M |
| 247 | PBH | Prestige Consumer Healthcare Inc. | 2.18B | -1.84% | 101,064 | 1.10B |
| 248 | UFPT | UFP Technologies, Inc. | 2.17B | 0.25% | 51,187 | 631.64M |
| 249 | ADUS | Addus HomeCare Corporation | 2.16B | -0.34% | 100,151 | 1.48B |
| 250 | TRVI | Trevi Therapeutics, Inc. | 2.16B | 0.87% | 606,175 | - |
| 251 | NUVB | Nuvation Bio Inc. | 2.15B | 6.14% | 2,610,768 | 169.90M |
| 252 | URGN | UroGen Pharma Ltd. | 2.15B | 1.32% | 300,132 | 188.73M |
| 253 | SRPT | Sarepta Therapeutics, Inc. | 2.14B | 2.73% | 936,383 | 1.97B |
| 254 | BFLY | Butterfly Network, Inc. | 2.14B | 10.61% | 3,016,700 | 112.14M |
| 255 | BHC | Bausch Health Companies Inc. | 2.13B | 0.26% | 442,888 | 10.85B |
| 256 | ALMR | Alamar Biosciences, Inc. | 2.13B | 4.37% | 235,836 | 100.42M |
| 257 | INSP | Inspire Medical Systems, Inc. | 2.12B | 0.98% | 156,186 | 898.74M |
| 258 | ZBIO | Zenas BioPharma, Inc. | 2.12B | 0.50% | 187,670 | 1.00M |
| 259 | SDGR | Schrödinger, Inc. | 2.10B | 17.30% | 3,698,560 | 259.04M |
| 260 | ESTA | Establishment Labs Holdings Inc. | 2.10B | -1.08% | 79,700 | 245.82M |
| 261 | KOD | Kodiak Sciences Inc. | 2.08B | 1.43% | 369,501 | - |
| 262 | MD | Pediatrix Medical Group, Inc. | 2.08B | 0.57% | 140,168 | 1.95B |
| 263 | PGNY | Progyny, Inc. | 2.08B | -1.10% | 324,964 | 1.31B |
| 264 | CMPS | COMPASS Pathways plc | 2.06B | 7.68% | 2,789,750 | - |
| 265 | AGIO | Agios Pharmaceuticals, Inc. | 2.02B | 2.90% | 189,436 | 98.34M |
| 266 | BHVN | Biohaven Ltd. | 2.02B | 11.31% | 1,837,804 | - |
| 267 | VCEL | Vericel Corporation | 2.02B | -2.11% | 192,805 | 306.30M |
| 268 | RAPP | Rapport Therapeutics, Inc. | 2.00B | 0.65% | 122,541 | 20.00M |
| 269 | ADMA | ADMA Biologics, Inc. | 2.00B | 0.17% | 522,090 | 512.28M |
| 270 | FTRE | Fortrea Holdings Inc. | 1.97B | 3.96% | 818,399 | 2.68B |
| 271 | ZYME | Zymeworks Inc. | 1.96B | 5.34% | 281,254 | 37.13M |
| 272 | GHRS | GH Research PLC | 1.95B | 2.49% | 234,845 | - |
| 273 | NVCR | NovoCure Limited | 1.95B | 3.27% | 356,842 | 699.19M |
| 274 | XRAY | DENTSPLY SIRONA Inc. | 1.93B | -4.29% | 3,567,953 | 3.64B |
| 275 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.92B | 8.04% | 1,056,415 | 208.78M |
| 276 | COAG | Hemab Therapeutics Holdings, Inc. | 1.92B | 0.22% | 200,994 | - |
| 277 | ALHC | Alignment Healthcare, Inc. | 1.91B | 5.86% | 14,311,138 | 4.58B |
| 278 | MESO | Mesoblast Limited | 1.91B | 3.33% | 77,047 | 120.25M |
| 279 | ALVO | Alvotech | 1.90B | 4.31% | 582,262 | 494.61M |
| 280 | PRGO | Perrigo Company plc | 1.88B | -0.15% | 558,124 | 4.14B |
| 281 | STOK | Stoke Therapeutics, Inc. | 1.87B | 3.91% | 316,422 | 27.59M |
| 282 | ASTH | Astrana Health, Inc. | 1.87B | -3.08% | 421,933 | 3.84B |
| 283 | VIR | Vir Biotechnology, Inc. | 1.86B | 4.75% | 681,842 | 303.23M |
| 284 | SEPN | Septerna, Inc. | 1.86B | 3.75% | 102,885 | 98.88M |
| 285 | RXRX | Recursion Pharmaceuticals, Inc. | 1.86B | 8.62% | 13,667,464 | 54.86M |
| 286 | SNDA | Sonida Senior Living, Inc. | 1.86B | -0.61% | 112,947 | 481.07M |
| 287 | LMAT | LeMaitre Vascular, Inc. | 1.83B | -0.22% | 63,616 | 262.43M |
| 288 | BRVE | Braveheart Bio, Inc. | 1.83B | 3.64% | 205,325 | - |
| 289 | XNCR | Xencor, Inc. | 1.81B | 2.78% | 325,870 | 104.97M |
| 290 | LKFT | Lakefront Biotherapeutics NV | 1.80B | 3.96% | 202,459 | 1.13B |
| 291 | BLFS | BioLife Solutions, Inc. | 1.80B | 1.66% | 184,619 | 106.69M |
| 292 | SGRY | Surgery Partners, Inc. | 1.78B | -1.69% | 2,330,244 | 3.37B |
| 293 | NBTX | Nanobiotix S.A. | 1.76B | 3.37% | 69,834 | 38.27M |
| 294 | NTLA | Intellia Therapeutics, Inc. | 1.75B | 8.88% | 3,311,025 | 59.51M |
| 295 | PSNL | Personalis, Inc. | 1.73B | 0.68% | 2,471,397 | 69.67M |
| 296 | TYRA | Tyra Biosciences, Inc. | 1.68B | 0.57% | 143,652 | - |
| 297 | TSHA | Taysha Gene Therapies, Inc. | 1.68B | 1.87% | 1,461,732 | 5.49M |
| 298 | FRNM | Freenome, Inc. | 1.68B | 6.04% | 377,148 | 35.41M |
| 299 | NVAX | Novavax, Inc. | 1.67B | 8.56% | 4,749,353 | 413.80M |
| 300 | IMCR | Immunocore Holdings plc | 1.66B | 2.22% | 72,857 | 430.78M |
| 301 | KLRA | Kailera Therapeutics, Inc. | 1.65B | 0.39% | 486,960 | - |
| 302 | ETON | Eton Pharmaceuticals, Inc. | 1.63B | 1.35% | 110,126 | 105.60M |
| 303 | ANAB | AnaptysBio, Inc. | 1.62B | 0.68% | 115,916 | 232.39M |
| 304 | LTGO | Latigo Biotherapeutics, Inc. | 1.61B | 5.12% | 75,467 | - |
| 305 | ANIP | ANI Pharmaceuticals, Inc. | 1.60B | 1.24% | 147,098 | 978.38M |
| 306 | SNDX | Syndax Pharmaceuticals, Inc. | 1.59B | 3.36% | 853,141 | 252.25M |
| 307 | KARD | Kardigan, Inc. | 1.59B | -2.02% | 237,987 | - |
| 308 | ABSI | Absci Corporation | 1.59B | 14.93% | 5,382,488 | 1.56M |
| 309 | INBX | Inhibrx Biosciences, Inc. | 1.56B | 3.86% | 91,442 | 1.30M |
| 310 | ATEC | Alphatec Holdings, Inc. | 1.55B | -4.48% | 835,165 | 815.05M |
| 311 | AGL | agilon health, inc. | 1.54B | 2.45% | 86,405 | 5.92B |
| 312 | ARDT | Ardent Health, Inc. | 1.53B | 1.26% | 65,236 | 6.41B |
| 313 | INVA | Innoviva, Inc. | 1.52B | -0.57% | 168,109 | 440.00M |
| 314 | KRSA | Korsana Biosciences, Inc. | 1.52B | 7.08% | 11,977 | - |
| 315 | DMRA | Damora Therapeutics, Inc. | 1.51B | 0.04% | 181,513 | - |
| 316 | NUTX | Nutex Health Inc. | 1.51B | 1.27% | 45,478 | 846.72M |
| 317 | HCSG | Healthcare Services Group, Inc. | 1.50B | -0.46% | 142,248 | 1.86B |
| 318 | AVLN | Avalyn Pharma Inc. | 1.49B | -2.85% | 45,917 | - |
| 319 | INNV | InnovAge Holding Corp. | 1.49B | 0.74% | 67,285 | 989.71M |
| 320 | BCAX | Bicara Therapeutics Inc. | 1.49B | 2.41% | 210,022 | - |
| 321 | OMCL | Omnicell, Inc. | 1.49B | 0.40% | 79,546 | 1.25B |
| 322 | AZTA | Azenta, Inc. | 1.48B | 1.42% | 159,900 | 613.81M |
| 323 | DRTS | Alpha Tau Medical Ltd. | 1.45B | 4.06% | 545,939 | - |
| 324 | XERS | Xeris Biopharma Holdings, Inc. | 1.44B | 1.29% | 701,482 | 335.41M |
| 325 | PAHC | Phibro Animal Health Corporation | 1.43B | -0.10% | 55,399 | 1.52B |
| 326 | KMTS | Kestra Medical Technologies, Ltd. | 1.43B | -0.37% | 100,975 | 106.73M |
| 327 | TRAX | First Tracks Biotherapeutics, Inc. | 1.43B | 2.44% | 295,786 | - |
| 328 | PNTG | The Pennant Group, Inc. | 1.42B | -4.21% | 824,510 | 1.10B |
| 329 | AAPG | Ascentage Pharma Group International | 1.40B | -1.43% | 2,282 | 94.61M |
| 330 | CNMD | CONMED Corporation | 1.39B | -1.04% | 51,533 | 1.37B |
| 331 | AVBP | ArriVent BioPharma, Inc. | 1.38B | 1.34% | 74,624 | - |
| 332 | CGEM | Cullinan Therapeutics, Inc. | 1.37B | 3.54% | 195,153 | - |
| 333 | SVRA | Savara Inc. | 1.37B | 5.07% | 446,312 | - |
| 334 | LBRX | LB Pharmaceuticals Inc | 1.36B | -1.08% | 56,047 | - |
| 335 | ORIC | ORIC Pharmaceuticals, Inc. | 1.34B | 2.87% | 345,852 | - |
| 336 | AMN | AMN Healthcare Services, Inc. | 1.33B | -1.52% | 213,189 | 3.43B |
| 337 | OMER | Omeros Corporation | 1.33B | 5.82% | 1,526,972 | 38.42M |
| 338 | MAZE | Maze Therapeutics, Inc. | 1.33B | -0.23% | 90,998 | 20.00M |
| 339 | RARE | Ultragenyx Pharmaceutical Inc. | 1.32B | 4.39% | 1,707,614 | 717.00M |
| 340 | VOR | Vor Biopharma Inc. | 1.31B | 0.82% | 588,775 | - |
| 341 | CERT | Certara, Inc. | 1.29B | 4.06% | 510,005 | 421.75M |
| 342 | AKTS | Aktis Oncology, Inc. | 1.27B | 0.18% | 180,603 | 10.06M |
| 343 | MGTX | MeiraGTx Holdings plc | 1.26B | 2.59% | 366,016 | 397.50M |
| 344 | USPH | U.S. Physical Therapy, Inc. | 1.25B | 0.36% | 69,292 | 804.27M |
| 345 | HROW | Harrow, Inc. | 1.24B | -3.48% | 311,436 | 275.59M |
| 346 | IART | Integra LifeSciences Holdings Corporation | 1.23B | -1.56% | 304,808 | 1.65B |
| 347 | OMDA | Omada Health, Inc. | 1.23B | 1.37% | 194,982 | 309.76M |
| 348 | CRON | Cronos Group Inc. | 1.22B | 2.74% | 368,000 | 179.09M |
| 349 | OPK | OPKO Health, Inc. | 1.22B | 1.55% | 692,503 | 587.90M |
| 350 | IMTX | Immatics N.V. | 1.22B | 3.01% | 228,678 | 47.65M |
| 351 | REPL | Replimune Group, Inc. | 1.21B | -0.85% | 380,903 | - |
| 352 | TNDM | Tandem Diabetes Care, Inc. | 1.20B | -1.31% | 720,582 | 1.04B |
| 353 | ANRO | Alto Neuroscience, Inc. | 1.20B | 1.63% | 104,434 | - |
| 354 | APMD | Apnimed, Inc. | 1.18B | 4.98% | 120,838 | 115.12M |
| 355 | SPTX | Seaport Therapeutics, Inc. | 1.17B | -1.08% | 91,752 | - |
| 356 | GDRX | GoodRx Holdings, Inc. | 1.17B | 1.33% | 206,016 | 785.23M |
| 357 | AORT | Artivion, Inc. | 1.17B | -4.36% | 108,030 | 471.47M |
| 358 | ODTX | Odyssey Therapeutics, Inc. | 1.17B | 5.28% | 186,334 | 99.00K |
| 359 | TDOC | Teladoc Health, Inc. | 1.16B | -0.62% | 914,949 | 2.49B |
| 360 | MNKD | MannKind Corporation | 1.15B | 0.85% | 1,014,710 | 393.63M |
| 361 | LMRI | Lumexa Imaging Holdings, Inc. | 1.13B | 0.94% | 48,397 | 1.04B |
| 362 | CSTL | Castle Biosciences, Inc. | 1.11B | 2.76% | 125,098 | 357.28M |
| 363 | PRCT | PROCEPT BioRobotics Corporation | 1.09B | -1.70% | 205,770 | 337.34M |
| 364 | BVS | Bioventus Inc. | 1.09B | -1.63% | 120,350 | 581.85M |
| 365 | STAA | STAAR Surgical Company | 1.09B | -3.03% | 259,422 | 339.59M |
| 366 | JBIO | Jade Biosciences, Inc. | 1.09B | 2.70% | 328,196 | - |
| 367 | OBX | Obsidian Therapeutics, Inc. | 1.09B | 2.62% | 149,781 | - |
| 368 | GLUE | Monte Rosa Therapeutics, Inc. | 1.08B | 0.24% | 549,367 | 28.73M |
| 369 | CRVS | Corvus Pharmaceuticals, Inc. | 1.07B | 4.01% | 811,776 | - |
| 370 | IRMD | IRADIMED CORPORATION | 1.06B | 0.64% | 41,661 | 86.34M |
| 371 | KURA | Kura Oncology, Inc. | 1.06B | 6.61% | 808,985 | 77.23M |
| 372 | ENOV | Enovis Corporation | 1.05B | -2.30% | 623,958 | 2.30B |
| 373 | ATTO | Attovia Therapeutics, Inc. | 1.05B | 3.37% | 82,341 | 1.80M |
| 374 | MLTX | MoonLake Immunotherapeutics | 1.05B | -1.20% | 437,355 | - |
| 375 | JANX | Janux Therapeutics, Inc. | 1.04B | 4.22% | 220,661 | 24.00M |
| 376 | ANL | Adlai Nortye Group Ltd. | 1.03B | 3.09% | 47,582 | 18.06M |
| 377 | SLBT | SL Science Holding Limited | 1.02B | -1.18% | 28,403 | 3.27M |
| 378 | ALMS | Alumis Inc. | 1.02B | -1.13% | 1,238,994 | 7.40M |
| 379 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.01B | -1.29% | 110,445 | 730.02M |
| 380 | ABUS | Arbutus Biopharma Corporation | 1.00B | 0.30% | 1,213,514 | 181.72M |
| 381 | PCRX | Pacira BioSciences, Inc. | 990.57M | -0.24% | 79,776 | 746.16M |
| 382 | SGP | SpyGlass Pharma, Inc. | 986.38M | 3.11% | 52,695 | - |
| 383 | GMRS | GMR Solutions Inc. | 976.18M | -3.16% | 181,672 | 5.88B |
| 384 | HELP | Cybin Inc. | 968.05M | -1.63% | 752,481 | - |
| 385 | CBLL | CeriBell, Inc. | 957.53M | 1.84% | 122,151 | 101.96M |
| 386 | BBNX | Beta Bionics, Inc. | 953.11M | -4.49% | 1,681,057 | 119.01M |
| 387 | SLDB | Solid Biosciences Inc. | 947.87M | 1.38% | 486,603 | - |
| 388 | SANA | Sana Biotechnology, Inc. | 947.48M | 8.39% | 1,358,667 | - |
| 389 | LXRX | Lexicon Pharmaceuticals, Inc. | 929.96M | 3.47% | 1,210,928 | 41.47M |
| 390 | IVA | Inventiva S.A. | 903.84M | -0.92% | 1,166,691 | 7.94M |
| 391 | WVE | Wave Life Sciences, Inc. | 903.47M | 1.78% | 619,669 | 65.37M |
| 392 | AVTX | Avalo Therapeutics, Inc. | 897.23M | 0.90% | 230,054 | 59.00K |
| 393 | FTH | Faeth Therapeutics, Inc. | 897.05M | 1.39% | 63,456 | - |
| 394 | HSTM | HealthStream, Inc. | 894.16M | -0.66% | 42,632 | 321.12M |
| 395 | IMMX | Immix Biopharma, Inc. | 887.80M | 4.11% | 428,546 | - |
| 396 | TBPH | Theravance Biopharma, Inc. | 883.66M | -0.06% | 103,718 | 104.31M |
| 397 | CADL | Candel Therapeutics, Inc. | 874.61M | 3.72% | 313,758 | - |
| 398 | OLMA | Olema Pharmaceuticals, Inc. | 873.23M | 2.57% | 339,777 | - |
| 399 | RIGL | Rigel Pharmaceuticals, Inc. | 862.92M | 3.86% | 36,850 | 276.79M |
| 400 | ARDX | Ardelyx, Inc. | 858.45M | 1.62% | 1,306,226 | 450.89M |
| 401 | GERN | Geron Corporation | 854.49M | 3.10% | 2,740,696 | 204.56M |
| 402 | INMD | InMode Ltd. | 839.79M | 0.21% | 122,268 | 374.63M |
| 403 | AVR | Anteris Technologies Global Corp. | 818.65M | 0.36% | 118,573 | 2.24M |
| 404 | ACHV | Achieve Life Sciences, Inc. | 816.02M | 6.87% | 621,786 | - |
| 405 | SIBN | SI-BONE, Inc. | 812.56M | -2.21% | 249,132 | 213.60M |
| 406 | BLSM | BlossomHill Therapeutics, Inc. | 808.99M | 0.57% | 64,589 | - |
| 407 | ACRS | Aclaris Therapeutics, Inc. | 798.55M | 1.97% | 2,307,818 | 8.22M |
| 408 | CLYM | Climb Bio, Inc. | 793.19M | -2.13% | 343,793 | - |
| 409 | FDMT | 4D Molecular Therapeutics, Inc. | 791.65M | 4.14% | 334,873 | 92.01M |
| 410 | DSGN | Design Therapeutics, Inc. | 788.22M | 0.72% | 165,587 | - |
| 411 | VREX | Varex Imaging Corporation | 779.32M | 0.11% | 122,794 | 865.00M |
| 412 | ANNX | Annexon, Inc. | 773.48M | 3.82% | 852,025 | - |
| 413 | AHCO | AdaptHealth Corp. | 769.77M | -2.37% | 723,380 | 3.36B |
| 414 | SLN | Silence Therapeutics plc | 768.87M | 2.16% | 195,492 | 615.00K |
| 415 | GLAS | Glass House Brands Inc. | 764.23M | 0.99% | 209,413 | 176.98M |
| 416 | QDEL | QuidelOrtho Corporation | 759.82M | 2.88% | 346,729 | 2.67B |
| 417 | GYRE | Gyre Therapeutics, Inc. | 757.08M | 6.57% | 69,354 | 109.82M |
| 418 | PHAR | Pharming Group N.V. | 750.09M | 1.90% | 3,102 | 366.48M |
| 419 | COLL | Collegium Pharmaceutical, Inc. | 731.85M | 1.31% | 235,270 | 808.21M |
| 420 | IRWD | Ironwood Pharmaceuticals, Inc. | 731.19M | 6.12% | 900,395 | 389.32M |
| 421 | CBIO | Crescent Biopharma, Inc. | 723.34M | -1.63% | 208,228 | 11.88M |
| 422 | ZVRA | Zevra Therapeutics, Inc. | 716.17M | 2.20% | 888,766 | 136.07M |
| 423 | DBVT | DBV Technologies S.A. | 715.71M | 6.23% | 104,517 | 5.04M |
| 424 | SOPH | SOPHiA GENETICS SA | 704.86M | 3.82% | 529,299 | 86.17M |
| 425 | NVCT | Nuvectis Pharma, Inc. | 698.87M | -1.92% | 28,357 | - |
| 426 | VSTM | Verastem, Inc. | 696.43M | 5.05% | 856,637 | 87.53M |
| 427 | STLN | Starling Oncology, Inc. | 695.07M | 4.44% | 1,063,534 | 587.24M |
| 428 | MDXG | MiMedx Group, Inc. | 692.36M | 0.42% | 311,414 | 355.17M |
| 429 | SGMT | Sagimet Biosciences Inc. | 688.72M | 5.93% | 442,360 | - |
| 430 | AURA | Aura Biosciences, Inc. | 688.60M | -1.34% | 291,250 | - |
| 431 | MNPR | Monopar Therapeutics Inc. | 677.39M | -0.52% | 132,102 | - |
| 432 | SSII | SS Innovations International, Inc. | 671.29M | 2.45% | 20,484 | 52.40M |
| 433 | CTKB | Cytek Biosciences, Inc. | 670.71M | 4.67% | 1,251,230 | 206.71M |
| 434 | NGNE | Neurogene Inc. | 668.38M | -3.66% | 50,203 | 925.00K |
| 435 | AHG | Akso Health Group | 642.61M | 0.67% | 493 | 13.83M |
| 436 | OABI | OmniAb, Inc. | 641.17M | 1.38% | 406,252 | 38.46M |
| 437 | ALT | Altimmune, Inc. | 637.05M | 1.08% | 1,440,209 | 31.00K |
| 438 | ANGO | AngioDynamics, Inc. | 636.11M | -0.45% | 218,654 | 320.17M |
| 439 | PHR | Phreesia, Inc. | 635.61M | - | 175,640 | 507.79M |
| 440 | MPLT | MapLight Therapeutics, Inc. | 629.67M | -0.61% | 101,003 | - |
| 441 | VALN | Valneva SE | 625.88M | 1.90% | 5,916 | 163.30M |
| 442 | OCS | Oculis Holding AG | 616.70M | 0.81% | 47,511 | 1.45M |
| 443 | CTMX | CytomX Therapeutics, Inc. | 616.65M | 2.35% | 1,651,346 | 18.30M |
| 444 | SCTX | Scribe Therapeutics Inc. | 614.52M | 11.55% | 148,464 | 33.30M |
| 445 | PHAT | Phathom Pharmaceuticals, Inc. | 613.99M | 0.52% | 377,505 | 239.66M |
| 446 | AQST | Aquestive Therapeutics, Inc. | 603.71M | -0.21% | 735,353 | 54.09M |
| 447 | CRMD | CorMedix Inc. | 600.95M | -1.41% | 228,321 | 462.25M |
| 448 | FLGT | Fulgent Genetics, Inc. | 595.71M | 0.09% | 82,262 | 323.93M |
| 449 | ALLO | Allogene Therapeutics, Inc. | 594.24M | 1.78% | 2,129,328 | 4.64M |
| 450 | STTK | Shattuck Labs, Inc. | 590.14M | - | 199,316 | 1.00M |
| 451 | WEAV | Weave Communications, Inc. | 586.79M | 0.20% | 616,716 | 257.79M |
| 452 | DRUG | Bright Minds Biosciences Inc. | 582.64M | 2.05% | 36,989 | - |
| 453 | AGMB | AgomAb Therapeutics NV | 582.36M | 3.64% | 112,058 | - |
| 454 | EVO | Evotec SE | 575.95M | 2.45% | 5,604 | 819.47M |
| 455 | PRME | Prime Medicine, Inc. | 574.63M | 7.67% | 1,562,909 | 4.07M |
| 456 | KIDS | OrthoPediatrics Corp. | 573.89M | -5.05% | 113,361 | 252.72M |
| 457 | DCTH | Delcath Systems, Inc. | 565.42M | 0.46% | 148,428 | 95.42M |
| 458 | PROK | ProKidney Corp. | 559.30M | - | 480,671 | 818.00K |
| 459 | CTEV | Claritev Corporation | 549.86M | -3.32% | 49,283 | 994.67M |
| 460 | CAPR | Capricor Therapeutics, Inc. | 548.83M | 10.28% | 2,514,085 | 11.13M |
| 461 | ARVN | Arvinas, Inc. | 544.01M | 1.96% | 174,329 | 316.70M |
| 462 | BWAY | BrainsWay Ltd. | 542.62M | 0.89% | 12,566 | 60.70M |
| 463 | TECX | Tectonic Therapeutic, Inc. | 540.34M | -0.97% | 48,567 | - |
| 464 | TLRY | Tilray Brands, Inc. | 539.75M | 0.25% | 1,177,316 | 915.45M |
| 465 | RGNX | REGENXBIO Inc. | 539.33M | 2.38% | 519,531 | 174.48M |
| 466 | EPRX | Eupraxia Pharmaceuticals Inc. | 532.96M | 3.58% | 108,412 | - |
| 467 | OVID | Ovid Therapeutics Inc. | 530.23M | 1.31% | 1,187,507 | 1.58M |
| 468 | DNA | Ginkgo Bioworks Holdings, Inc. | 528.62M | 11.19% | 1,341,353 | 132.42M |
| 469 | CERS | Cerus Corporation | 520.94M | 2.17% | 1,479,882 | 221.55M |
| 470 | ENTX | Entera Bio Ltd. | 519.43M | 1.35% | 162,475 | 42.00K |
| 471 | ASMB | Assembly Biosciences, Inc. | 518.38M | -0.08% | 151,244 | 74.85M |
| 472 | EOLS | Evolus, Inc. | 517.84M | -1.88% | 442,322 | 316.49M |
| 473 | AUTL | Autolus Therapeutics plc | 512.36M | 2.94% | 613,350 | 117.39M |
| 474 | TCMD | Tactile Systems Technology, Inc. | 506.51M | 0.86% | 91,104 | 350.31M |
| 475 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 476 | KMDA | Kamada Ltd. | 501.87M | 6.72% | 93,793 | 191.85M |
| 477 | SENS | Senseonics Holdings, Inc. | 501.51M | 4.69% | 410,856 | 48.55M |
| 478 | ARCT | Arcturus Therapeutics Holdings Inc. | 500.25M | 12.82% | 625,807 | 29.37M |
| 479 | CTNM | Contineum Therapeutics, Inc. | 494.34M | -4.51% | 185,113 | - |
| 480 | PBYI | Puma Biotechnology, Inc. | 492.46M | 1.60% | 71,550 | 231.24M |
| 481 | VOGX | Vogenx, Inc. | 487.12M | 4.82% | 70,751 | - |
| 482 | NPCE | NeuroPace, Inc. | 483.97M | - | 45,114 | 106.99M |
| 483 | EIKN | Eikon Therapeutics, Inc. | 476.65M | 3.41% | 234,558 | - |
| 484 | NRC | NRC Health | 475.79M | -2.45% | 28,989 | 140.00M |
| 485 | SRTA | Strata Critical Medical, Inc. | 475.51M | 2.97% | 140,874 | 255.98M |
| 486 | PRLD | Prelude Therapeutics Incorporated | 472.75M | 2.68% | 279,581 | 22.42M |
| 487 | INDP | Indaptus Therapeutics, Inc. | 464.35M | 8.57% | 431,711 | - |
| 488 | RLMD | Relmada Therapeutics, Inc. | 457.61M | 1.66% | 243,755 | - |
| 489 | MASS | 908 Devices Inc. | 455.08M | 10.99% | 378,671 | 60.84M |
| 490 | SGHT | Sight Sciences, Inc. | 444.56M | -0.86% | 47,926 | 83.38M |
| 491 | ZURA | Zura Bio Limited | 440.81M | -0.22% | 849,539 | - |
| 492 | IRD | Opus Genetics, Inc. | 437.61M | -2.77% | 589,652 | 9.86M |
| 493 | EDIT | Editas Medicine, Inc. | 436.17M | 4.80% | 1,862,012 | 47.01M |
| 494 | PRTA | Prothena Corporation plc | 435.85M | 3.03% | 128,859 | 54.53M |
| 495 | KYTX | Kyverna Therapeutics, Inc. | 434.76M | 1.88% | 212,324 | - |
| 496 | PACB | Pacific Biosciences of California, Inc. | 432.05M | 3.73% | 3,735,014 | 159.27M |
| 497 | CABA | Cabaletta Bio, Inc. | 431.49M | 2.21% | 1,994,420 | - |
| 498 | IKT | Inhibikase Therapeutics, Inc. | 426.97M | 1.52% | 214,627 | 1.00 |
| 499 | EVH | Evolent Health, Inc. | 425.67M | 0.67% | 661,467 | 2.10B |
| 500 | AVIR | Atea Pharmaceuticals, Inc. | 425.08M | 2.91% | 88,968 | - |